How Does The MFDS Review Clinical Data For Drug Registration?

The MFDS reviews clinical data for drug registration by evaluating study design, methodologies, and results to ensure scientific rigor and validity. It assesses safety and efficacy data from preclinical and clinical trials, considering potential risks and benefits. The MFDS may request additional information or conduct inspections to verify compliance with regulatory standards.

Leave a Reply

You must be logged in to post a comment.